Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Nutr.

Sec. Nutrition and Food Science Technology

Volume 12 - 2025 | doi: 10.3389/fnut.2025.1637637

This article is part of the Research TopicHealth Effects of Natural Compounds from PlantsView all 12 articles

Synergy Analysis of Cyanidin-3-O-Glucoside and Catechin: Absorption, Transport and Lipid Metabolism Effects

Provisionally accepted
Hangyu  LiuHangyu Liu1Tienan  XiangTienan Xiang2Qianxi  ZangQianxi Zang1Meihong  LiuMeihong Liu1*Yuying  WangYuying Wang1Wandi  YinWandi Yin1Jingsheng  LiuJingsheng Liu1
  • 1Jilin Agriculture University, Changchun, China
  • 2Jilin Engineering Vocational College, Changchun, China

The final, formatted version of the article will be published soon.

Hyperlipidemia represents a global metabolic epidemic with increasing prevalence, profoundly associated with the etiology of cardiovascular and cerebrovascular diseases. This study investigates the therapeutic potential of two widely distributed bioactive polyphenols, Cyanidin-3-O-glucoside (C3G), catechin, and their synergistic combinatorial formation (C3G-catechin) in modulating hyperlipidemia, using complementary in vitro models (Caco-2 monolayer and Caco-2/HepG2 coculture systems) to simulate intestinal absorption dynamics and lipid metabolic regulation. Our results reveal that the intestinal absorption efficiency follows the order of catechin > C3G-catechin > C3G, primarily mediated through passive diffusion. Furthermore, these polyphenols exhibited significant hypolipidemic effects by downregulating the transcriptional and translational levels of lipid metabolism-related genes, such as SREBP-1, PPARγ, and FAS. This downregulation led to a reduction in key metabolites, including total cholesterol, triglycerides, and LDL-C. Notably, the C3G-catechin combination demonstrated superior regulatory efficacy compared to the individual compounds, suggesting synergistic bioactivity. This study provides mechanistic insights into the enteric transport dynamics and metabolic modulation of dietary polyphenols, highlighting their therapeutic potential to reduce harmful cholesterol level. These findings propose new perspectives for developing nutritional health foods aimed at preventing and treating hyperlipidemia.

Keywords: Polyphenols, Cyanidin-3-O-glucoside, Catechin, Cholesterol, Lipid Metabolism, Hyperlipidemia

Received: 29 May 2025; Accepted: 28 Jul 2025.

Copyright: © 2025 Liu, Xiang, Zang, Liu, Wang, Yin and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Meihong Liu, Jilin Agriculture University, Changchun, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.